In this minisode, Mindy and Ryan examine a few recent newsworthy items including trends impacting digital health funding (0:48), the newly operational 988 mental health and suicide crisis line (4:00), the latest impacts on the healthcare industry post Roe v. Wade (6:45), and discussions regarding the future of the 340B prescription drug program (13:49).
Podcast Tags: healthcare, healthcare news, women’s health, reproductive health, public health, providers, Roe v. Wade, mental health, maternal health, digital health, Medicaid, prescription drugs, Life Sciences
· H1 2022 digital health funding: Two sides to every correction | Rock Health
· Characteristics of U.S. Abortion Patients in 2014 and Changes Since 2008 | Guttmacher Institute
· Merck joins other drugmakers in cutting off sales to 340B contract pharmacies | Fierce Healthcare
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
Ryan Hummel, Executive and Head of Provider Sector